Targeted approach: Australian regulator finds fewer supplements rule breaches

By Tingmin Koe

- Last updated on GMT

The TGA has adopted a more targeted approach when selecting the listed medicines to be tested as part of its post-market compliance review. © Getty Images
The TGA has adopted a more targeted approach when selecting the listed medicines to be tested as part of its post-market compliance review. © Getty Images
A report from Australian regulator the Therapeutic Goods Administration (TGA) found that the percentage of health supplements that breached regulatory compliances in the second half of last year was less than that of 2018.

This is despite the regulator adopting a more targeted approach on how it selects the types of products for testing. 

In Australia, health supplements are regulated as listed medicines and the regulator conducts post-market compliance reviews on selected products.

In its ‘Half Yearly Performance Snapshot – 1 July to 31 December 2019’​ report, the TGA said that out of the 92 selected products which have completed the compliance review, 63 of them (68%) were verified to have breached regulatory compliance.

This percentage was lower than that of the same period in 2018, where the proportion of the 57 products with verified compliance breaches was 90%. 

In total, the TGA had conducted compliance review on 105 listed medicines in the reporting period, off which, 92 had completed the review. The compliance status for the remaining 13 products were unable to be determined.

Reasons include sponsors/manufacturers cancelling the product registration after the regulator had requested for more information or because the products were not yet manufactured.

More targeted reviews

A TGA spokesman told NutraIngredients-Asia ​that a more targeted approach was used when selecting the listed medicines to be tested.

The selection was done via the use of an internal data analytics where products with potential high-risk compliance issues were sieved out.

As such, there was more targeted review (82%) than random reviews (18%) conducted during the reporting period.  

This was a reversal from 2018, where random reviews took up the majority at 79% and targeted review at 21%.

The key criteria for how the listed medicines were selected include signals received from customers, the industry and the other areas of the TGA, the spokesman said.

According to our risk-based approach, we may assess compliance with either a broad range or a narrow set of specific listing requirements.

“The scope is determined based on information that the TGA possess about the medicine or the sponsor,” ​the spokesman said.

The regulator has also made the results of its listed medicine compliance review publicly available​ since end of last Dec.

More product applications

Last year, the regulator also saw more applications for new listed medicines. A total of 1,141 was received and this is a 21% increase from the same period in 2018.

The TGA said that was most likely because of companies transitioning to permitted indications.

Related news

Show more

Related products

show more

ACTRISAVE™ NATURAL SUPPORT FOR SKIN AND MALE HAIR

ACTRISAVE™ NATURAL SUPPORT FOR SKIN AND MALE HAIR

Content provided by BIONAP BIOACTIVE NATURAL PRODUCTS | 04-Sep-2024 | Product Brochure

ACTRISAVE™ is a powdered extract obtained from the patented association between black rice (Oryza sativa L.) and the flowers of prickly pear (Opuntia ficus-indica...

Your guide to nutritional care innovation

Your guide to nutritional care innovation

Content provided by dsm-firmenich | 22-Aug-2024 | Insight Guide

The medical nutrition market is primed for innovation due to aging populations, chronic diseases, nutrition awareness and scientific advances. Our comprehensive...

ATP + Creatine: The Ultimate Performance Boost

ATP + Creatine: The Ultimate Performance Boost

Content provided by TSI Group | 20-Aug-2024 | White Paper

Creatine is a highly researched supplement known for enhancing exercise performance by rapidly producing energy. When combined with ATP, this duo enhances...

Related suppliers

Follow us

Products

View more

Webinars

Nutra Champions Podcast